openPR Logo
Press release

Intravitreal IVT Injectable Market Share and Growth 2022- Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Bausch & Lomb

11-14-2022 07:04 AM CET | Health & Medicine

Press release from: Persistence Market Research

According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value.

Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete blindness. Intravitreal injection is a safe and easy method of treating retinal disorders.

According to the National Eye Institute (NEI), around 2.0 million people in the United States were afflicted by AMD in 2010, with the figure anticipated to more than increase to 5.4 million by 2050. To address rising demand, industry players are focused on innovation by developing a solid pipeline of IVT injections for the treatment of retinal diseases.

Request For Free Sample Report of Intravitreal (IVT) Injectable Market @ https://www.persistencemarketresearch.com/samples/25906

Between 2022 and 2028, North America is expected to account for a significant share of the global market. Increased incidence of age-related macular degeneration (AMD) is expected to stimulate demand for intravitreal (IVT) injectables in the United States.

Due to an increase in the elderly population and an increase in the incidence of retinal illnesses, the European market is also expected to fuel market growth. In the coming years, countries such as India and China are likely to boost demand for intravitreal (IVT) injectables in the Asia Pacific region, due to the presence of a sizable patient pool suffering from diabetes mellitus.

Companies

Hoffmann-La Roche Ltd

Regeneron Pharmaceuticals, Inc.

Bausch & Lomb

Novartis AG

Allergan

Alimera Sciences

ThromboGenics, Inc.

Bristol-Myers Squibb Company

For critical insights on this market, request for customization here@ https://www.persistencemarketresearch.com/request-customization/25906

Intravitreal (IVT) Injectable Market Categorization

Intravitreal (IVT) Injectable Market by Indication

Macular Degeneration

Diabetic Retinopathy

Retinal Vein Occlusion

Endophthalmitis

Others

Intravitreal (IVT) Injectable Market by Drug Class

Anti-VEGF

Corticosteroids

Antibiotics

Antivirals

Antifungals

Intravitreal (IVT) Injectable Market by Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa (MEA)

Buy The Complete Report to read the analysed strategies adopted by the top vendors either to retain or gain market share@ https://www.persistencemarketresearch.com/checkout/25906

PMR has presented a comprehensive report based on Molecular Diagnostic Reagent Market as per Material (Sample Preparation Kits, PCR Assay Kits, In situ Hybridization Kits, Microarray Kit, and Sequencing Kit), Application (Pathogen Detection, Biomarker Screening, Therapeutic Monitoring and others), End User (Hospitals, Laboratories, Research Institutes, Biopharmaceutical Companies and others) based on seven regions.

Top Market Research Reports:

Myoelectric Prosthetics Market: https://www.persistencemarketresearch.com/market-research/Myoelectric-Prosthetics-Market.asp

Franz Cell and Vapometer Market: https://www.persistencemarketresearch.com/market-research/Franz-Cell-and-Vapometer-Market.asp

ECG Devices Market: https://www.persistencemarketresearch.com/market-research/ECG-Devices-Market.asp

Clinical Trial Management System Market: https://www.persistencemarketresearch.com/market-research/Clinical-Trial-Management-System-Market.asp

Secure Messaging In Healthcare Market: https://www.persistencemarketresearch.com/market-research/Secure-Messaging-In-Healthcare-Market.asp

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravitreal IVT Injectable Market Share and Growth 2022- Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Bausch & Lomb here

News-ID: 2804767 • Views:

More Releases from Persistence Market Research

Touchscreen Controller Market to Reach USD 18.7 Billion by 2032, Registering an 8.6% CAGR (2025-2032)
Touchscreen Controller Market to Reach USD 18.7 Billion by 2032, Registering an …
Overview of the Touchscreen Controller Market The global touchscreen controller market is witnessing substantial growth, projected to increase from US$10.5 billion in 2025 to US$18.7 billion by 2032, expanding at a CAGR of 8.6% during the forecast period. This impressive growth is primarily fueled by the rising adoption of touch-enabled devices across diverse sectors such as consumer electronics, automotive, industrial automation, and healthcare. As devices like smartphones, tablets, infotainment systems, and
Global Railway Traction Motors Market to Reach US$15.29 Bn by 2032, Rising at a CAGR of 4.36% from 2025 to 2032
Global Railway Traction Motors Market to Reach US$15.29 Bn by 2032, Rising at a …
The global Railway Traction Motors Market is poised for steady growth, expanding from an estimated valuation of US$10.87 billion in 2025 to approximately US$15.29 billion by 2032. This growth reflects a compound annual growth rate (CAGR) of 4.36% during the forecast period of 2025-2032. The comprehensive report on the market provides a detailed evaluation of current industry trends, historical performance, and future projections. It offers in-depth qualitative and quantitative insights
Point of Sale Automation System Industry Forecasted to Grow at a 9.8% CAGR, Surpassing USD 37.2 Billion by 2032
Point of Sale Automation System Industry Forecasted to Grow at a 9.8% CAGR, Surp …
Overview of the Point of Sale Automation System Market The global Point of Sale (POS) Automation System Market is witnessing a transformative phase as businesses worldwide embrace digital payment technologies and automated transaction systems. The market is projected to be valued at US$ 19.3 billion in 2025 and is expected to reach US$ 37.2 billion by 2032, registering an impressive CAGR of 9.8% during the forecast period (2025-2032). This growth reflects
Global Automotive Chemicals Market to Reach US$ 39.8 Bn by 2032, Expanding at a 3.1% CAGR
Global Automotive Chemicals Market to Reach US$ 39.8 Bn by 2032, Expanding at a …
The global Automotive Chemicals Market is poised for steady growth, expected to be valued at US$ 32.1 billion in 2025 and projected to reach US$ 39.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 3.1% between 2025 and 2032. The newly released report by Persistence Market Research provides a comprehensive analysis of market dynamics, competitive landscape, segmental performance, and emerging opportunities shaping the automotive chemicals industry

All 5 Releases


More Releases for IVT

Intravitreal (IVT) Injectable Market Dynamics: Driving Forces Behind Market Expa …
The healthcare sector, especially in the field of ophthalmology, is witnessing significant growth due to the rising prevalence of eye diseases and advancements in injectable drug delivery systems. One of the most important developments in the treatment of retinal diseases has been the introduction of intravitreal (IVT) injectables. These injectable therapies are used to treat a range of eye conditions, such as age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic
Intravitreal (IVT) Injectable Market Transformative Innovations and Future Growt …
𝑰𝒏𝒕𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏 The Intravitreal (IVT) injectable market has emerged as a pivotal segment in ocular therapeutics, driven by the increasing prevalence of retinal disorders and advancements in drug delivery technologies. Intravitreal injections, administered directly into the vitreous humor, have revolutionized the treatment of various ocular conditions such as age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). This article explores the transformative innovations shaping the IVT injectable market
Intravitreal (IVT) Injectable Market Size, Share, Industry, Forecast (2024-2031)
Market Overview: The global intravitreal injectable market is growing at a CAGR of 5.8% during the forecast period of 2024-2031. Key drivers of market growth include the increasing prevalence of chronic retinal diseases, particularly cataracts, and advancements in drug development by key manufacturers to meet patient needs. However, market growth may be hindered by the risks associated with intravitreal injections. Market Dynamics: Growing Prevalence of Cataracts: Cataracts, which are the primary cause of
The Intravitreal (IVT) Injectable Market To Prove Its Servility To Technological …
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value. Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete
The Intravitreal IVT Injectable Market to Witness Invigorating Trends
The Intravitreal IVT Injectable Market is expected to grow on an irreversible note in the next 10 years. The future scenario would be data-driven healthcare. This would, in turn, widen the potential for enhancing treatment options. With interoperability taking the centre stage, program participants could access app blueprints, data templates, and security tools. Thus, the big data cloud would turn out to be kinetic. This would result in an upswing
The Intravitreal IVT Injectable Market to grow on an invincible note
The Intravitreal IVT Injectable Market is expected to grow by leaps and bounds in the forecast period. Nanotechnology’s medical application is on the anvil. As such, nanomedicine is an outcome of the technology operating at the molecular, atomic, or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the healthcare vertical upgraded continuously. Hereditary retinal diseases is the major